Pembrolizumab (pembro; MK-3475) for advanced melanoma (MEL): Randomized comparison of two dosing schedules Meeting Abstract
| Authors: | Robert, C.; Joshua, A. M.; Weber, J. S.; Ribas, A.; Hodi, F. S.; Kefford, R. F.; Daud, A.; Wolchok, J. D.; Hwu, W. J.; Gangadhar, T. C.; Patnaik, A.; Hersey, P.; Dronca, R.; Zarour, H.; Ge, Y.; Lindia, J. A.; Giannotti, M.; Ebbinghaus, S.; Kang, S. P.; Hamid, O. |
| Abstract Title: | Pembrolizumab (pembro; MK-3475) for advanced melanoma (MEL): Randomized comparison of two dosing schedules |
| Meeting Title: | 39th ESMO Congress (ESMO 2014) |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2014 Sep 26-30 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-09-01 |
| Language: | English |
| ACCESSION: | WOS:000346901000007 |
| DOI: | 10.1093/annonc/mdu438.42 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA34 -- Source: Wos |
